Skip to main content
Figure 3 | BMC Gastroenterology

Figure 3

From: Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case–control study

Figure 3

Combined action of current exposure to bisphosphonates, concurrent exposure to other medicaments and categories of Charlson comorbidity index on the risk of upper gastrointestinal complications. AIFA-BEST Project, Italy, 2003–2007. Odds ratios estimated with conditional logistic regression model. Estimates were obtained by including the interaction terms combining the effect of current exposure to BPs together with concurrent use of other medicaments and the categories of the Charlson index. P-values concern comparison of BPs effect across patient subgroups. BPs: Bisphosphonates.

Back to article page